Researchers at the University of Leeds led by Professors Sheena Radford and Neil Ranson have uncovered new information about the operation of a protein complex called BAM – the beta-barrel assembly machinery – which helps insert other bacterial proteins into the bacteria’s outermost protective layer.
In order for bacteria to spread diseases, they need to form an outer membrane, or they cannot survive in the harsh environments in which they live.
The BAM complex plays a crucial role in this process, facilitating the insertion of a myriad of proteins into this layer that are required for it to work properly as a barrier, protecting the bug from attack by antibiotics.
Professor Ranson said: “This is a complex molecular machine involved in keeping bacteria alive, and we know that mutations in it are lethal to the bacteria.
"Some beautiful work by other labs has shown that BAM exists in two different shapes – an open and closed form - but the open form seemed to require part of the complex to fall apart.
"Our work shows for the first time the intact BAM complex in this open state. Now we have been able to see the intact structure in this way, it gives us new clues about how BAM works and about how to develop ways to stop it functioning.”
The research was carried out using electron microscopes based at the Diamond Light Source, the UK’s national synchrotron science facility, located at the Harwell Science and Innovation Campus in Oxfordshire.
However, it is now possible to carry out the next steps in this research on campus in Leeds, following the University's investment in its own state of the art electron microscopes. The two microscopes form a key part of the leading edge facilities at the Astbury Centre for Structural Molecular Biology.
Professor Radford, Director of the University’s Astbury Centre, said “If BAM cannot do its job, bacteria won’t survive and they would be prevented from spreading diseases.
"The challenge, now we understand more about how BAM works, is for the scientific community to develop drugs which can target it and replenish our shrinking arsenal of antibiotics to treat bacterial infections.”
The new understanding will contribute to ongoing work to find new ways to kill bacteria which have become increasingly resistant to drugs developed in 20thcentury.
Antibacterial resistance has become a major issue in recent years, with many drugs developed to combat infections from whooping cough to salmonella, and a wide range of hospital-acquired infections, losing their effectiveness.
Previously scientists have used X-ray crystallography, which has been the mainstay of structural discovery for several decades, to show that the barrel-shaped BAM complex could exist in both open and closed forms.
The BAM complex sits within the outer membrane of Gram-negative bacteria, and inserts other proteins into the membrane where they are needed to form a functional protective layer. How this happens is not properly understood, but the change in shape is thought to be essential to allow its client proteins to enter the membrane.
Using highly advanced electron microscopes, Professors Radford and Ranson now have seen the structure of BAM in an open state by rapidly freezing the complex from solution.
Previous structures of the open state all lacked one of the five proteins that make the full BAM complex, called BamB. The new results show that opening of the BAM barrel can happen with BamB there, and this changes the way scientists think about how BAM might work.
The full paper, Lateral opening in the intact β-barrel assembly machinery captured by cryo-EM, is published today in the Nature Communications journal.
Journalists requiring interviews or further information should contact Peter Le Riche in the University press office on 0113 343 2049 or email email@example.com.
Miriam Wittman, Stacey Martin, Edward Vital, Lupus UK (Oct 2016), £108,715
Juan Fontana Jordan De Urries, Royal Society
(Sep 2016), £110,850
John Barr, Public Health England
(Sep 2016), £110,341
Helen Miller, DSM Nutritional Products A/S (Sep 2016), £110,235
Joseph Cockburn, Wellcome Trust (Sep 2016), £109,934
Steven Clapcote, Vitaflo International Ltd (Sep 2016), £109,119
Nicola Stonehouse, Favid Rowlands, Morgan Herod, BBSRC (Sep 2016), £108,050
Jing Li, Sarah Calaghan, Mark Drinkhill, British Heart Foundation (Sep 2016), £108,969
Glyn Hemsworth, BBSRC (Sep 2016), £1,024,034
Glyn Hemsworth, BBSRC (Sep 2016), £107,767
Jayne David, Paul Millner, MRC (Aug 2016), £108,350
Sheena Radford, Alison Ashcroft, BBSRC (Aug 2016), £457,215
Sheena Radford, Alison Ashcroft, BBSRC (Aug 2016), £107,990
Patricija Van Oosten-Hawle, Dave Westhead, An-Jung Chen, NC3Rs (Aug 2016), £354,456
Peter Henderson, EU - European Union
EU - European Union
(Jul 2016), £123,897
Adrian Goldman, EU - European Union
(Jul 2016), £116,290
Urwin, Howard Atkinson, NERC
(Jul 2016), £105,053
Eileen Ingham and colleagues in Engineering and M&H, EPSRC (Jul 2016), £3,867,449
Michael Colman, MRC (Jul 2016), £200,956
Tim Benton, Fresca Group Ltd
(Jul 2016), £52,082
Derek Steele, Sarah Calaghan, Chris Peers, BHF (Jul 2016), £819,241
Paul Millner and colleagues in Engineering and M&H, BBSRC (Jul 2016), £129,647
Vas Ponnambalam, Darren Tomlinson, Stephen Wheatcroft, BHF (Jul 2016), £107,359
John Colyer, Christian Teade and colleagues in M&H, Kidney Research Fund UK (Jul 2016), £39,964
Nicola Stonehouse, David Rowlands, World Health Organisation (Jul 2016), £656,545
Alexander Breeze, MRC
(Jul 2016), £403,513
Yoselin Benitez-Alfonso and colleagues in MaPS, Leverhulme Trust (Jul 2016), £353,301
Joan Boyes, Peter Stockley, Roman Tuma, David Westhead, Bloodwise (Jul 2016), £232,960
Edwin Chen, Leuka
(Jul 2016), £98,642
Helen Miller, Hamlet Protein A/S
(Jul 2016), £22,240
Alexander Breeze, Syngenta
(Jul 2016), £299,629
Alan Berry, Wellcome Trust
(Jul 2016), £599,375
Amanda Bretman, Elizabeth Duncan, Leverhulme Trust
(Jul 2016), £245,369
Andrew Macdonald, Neil Ranson, Richard Foster, Yorkshire Kidney Research Fund (Jul 2016), £51,368
Roman Tuma, Sheena Radford, BBSRC
(Jul 2016), £379,786
Adrian Whitehouse, Ian Carr, Worldwide Cancer Research (Jul 2016), £199,738
Paul Milner, Mike McPherson, Lars Jeuken, Darren Tomlinson and colleagues in Engineering & M&H, MRC (Jul 2016), £3,124,568
Helen Miller, Innovate UK (Jun 2016), £3,463,470
Adrian Goldman, Royal Society
(Jun 2016), £250,000
Jim Deuchars, Susan Deuchars, Shaunna Burke, Dunhill Medical Trust (Jun 2016), £86,570
Keith Hamer, Guy Ziv, DEFRA Dept for Env. Food & Rural Affairs
(Jun 2016), £300,122
Richard Bayliss, EU - European Union
(Jun 2016), £373,565
Sheena Radford, Eric Hewitt, Alison Ashcroft, Andrew Wilson, EPSRC (Jun 2016), £458,278
Jamel Mankouri, John Barr, British Lung Foundation
(Jun 2016), £24,000
Zahrah Timsah, Wellcome Trust (Jun 2016), £100,000
Andrew Macdonald, Kidney Research Fund UK
(Jun 2016), £63,653
Edwin Chen, Academy of Medical Sciences
(Jun 2016), £98,110
Adrian Goldman, Royal Society (May 2016), £250,000
Peter Stockley, Wellcome Trust (May 2016), £1,246,487
John Ladbury, Christopher Jones, Cancer Research UK
(May 2016), £6,905
Elton Zaqiraj, Wellcome Trust (May 2016), £1,093,823
Alison Baker, Miller Camargo-Valero, BBSRC
(May 2016), £553,691
Adrian Whitehouse, Julie Aspden, Ian Carr, BBSRC (May 2016), £466,043
Peter Urwin, BBSRC (May 2016), £432,379
John Trinick, Elwyn Issac, Leverhulme Trust
(May 2016), £171,742
, British Council, UK
(May 2016), £11,100
Mark Harris, Horserace Betting Levy Board
(Apr 2016), £10,000
Peter Stockley, Neil Ranson, Roman Tuma, David Rowlands, MRC (Apr 2016), £341,225
Jamel Mankouri, Royal Society (Apr 2016), £332,396
Andrew Tuplin, MRC (Apr 2016), £508,170
Simon Goodman, British Council, UK
(Mar 2016), £35,800
, British Council, UK
(Mar 2016), £12,802
Katie Field, NERC
(Mar 2016), £186,411
Isuru Jayasinghe, Royal Society
(Mar 2016), £14,919
William Hoppitt, EU (Feb 2016), £34,345
Helen Miller, ABNA Ltd (Feb 2016), £115,000
Sarah Calaghan, Isuru Jayasinghe, BHF (Jan 2016), £52,050
Edwin Chen, Wellcome Trust (Jan 2016), £98,341
Patricija Van Oosten-Hawle, Wellcome Trust (Jan 2016), £89,900
James Duce, Alzheimer's Society (Jan 2016), £84,834
Andrew Smith, Rosetrees Trust (Jan 2016), £20,000
Richard Bayliss, BBSRC (Jan 2016), £345,796
Richard Bayliss, Cancer Research UK (Jan 2016), £283,616
Richard Bayliss, MRC (Jan 2016), £200,088
Thomas Edwards and colleagues in the School of Chemistry, EPSRC (Jan 2016), £2,228,732
David Brockwell, Sheena Radford, BBSRC (Dec 2015), £358,570
Stephanie Wright, Kay Kendall Leukaemia Fund (Dec 2015), £207,286
Stefan Kepinski, Michelle Peckham, BBSRC (Nov 2015), £461,760
Ryan Seipke, BBSRC (Nov 2015), £340,536
Paul Knox, BBSRC (Nov 2015), £40,000
Helen Miller, Agriculture & Horticulture Develpmnt Brd (Oct 2015), £63,560